Your browser doesn't support javascript.
loading
A Circulating MicroRNA Panel for Malignant Germ Cell Tumor Diagnosis and Monitoring.
Murray, Matthew J; Scarpini, Cinzia G; Coleman, Nicholas.
Afiliação
  • Murray MJ; Department of Pathology, University of Cambridge, Cambridge, UK. mjm16@cam.ac.uk.
  • Scarpini CG; Department of Paediatric Haematology and Oncology, Addenbrooke's Hospital, Cambridge, UK. mjm16@cam.ac.uk.
  • Coleman N; Department of Pathology, University of Cambridge, Cambridge, UK.
Methods Mol Biol ; 2195: 225-243, 2021.
Article em En | MEDLINE | ID: mdl-32852767
Reverse transcription (RT) based quantitative PCR (qPCR) for quantifying microRNAs (miRNAs) in in the circulation presents specific challenges. Here, we describe an optimized research protocol to assess serum sample quality and quantify levels of a panel of four test miRNAs (miR-371a-3p, miR-372-3p, miR-373-3p, and miR-367-3p) that enables highly sensitive and specific malignant germ cell tumor (GCT) diagnosis and monitoring. This protocol utilizes a multiplex RT step using Taqman miRNA stem-loop primers. A multiplexed preamplification stage is then employed to increase the sensitivity of the final quantification step, which is performed using standard singleplex Taqman qPCR methodology.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Neoplasias Embrionárias de Células Germinativas / MicroRNA Circulante Tipo de estudo: Diagnostic_studies / Guideline / Prognostic_studies Limite: Humans Idioma: En Revista: Methods Mol Biol Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Neoplasias Embrionárias de Células Germinativas / MicroRNA Circulante Tipo de estudo: Diagnostic_studies / Guideline / Prognostic_studies Limite: Humans Idioma: En Revista: Methods Mol Biol Ano de publicação: 2021 Tipo de documento: Article